Photobiomodulation for Itching

CR
MC
Overseen ByMargaret Chou, MD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: Massachusetts General Hospital
Must be taking: Antipruritics

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is designed to evaluate the safety and effectiveness of a low-level near-infrared LED light device for relieving itch. The device is non-invasive, does not break the skin, and does not produce heat. Near-infrared light has been used in other medical settings and is known to interact with skin and nerve pathways. In this study, researchers are examining whether this light can be safely applied to the skin and whether it may help reduce itch by affecting signals involved in itch sensation.

Who Is on the Research Team?

RR

Richard R. Anderson, MD

Principal Investigator

Massachusetts General Hospital

Are You a Good Fit for This Trial?

Inclusion Criteria

3. Participant is able and willing to comply with all the study visit, treatment, and evaluation schedules and requirements.
My average pain score was less than 4 last week.
My average pain score was between 4 and 7 last week.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive low-level near-infrared LED light treatment or placebo for itch relief

2 weeks
7 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Photobiomodulation

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Low-Level Near-Infrared LED Light TreatmentExperimental Treatment1 Intervention
Group II: Matching placeboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+